First Time Loading...

Pharmanutra SpA
MIL:PHN

Watchlist Manager
Pharmanutra SpA Logo
Pharmanutra SpA
MIL:PHN
Watchlist
Price: 47.4 EUR 1.94% Market Closed
Updated: May 15, 2024
Section:
 

Relative Value

The Relative Value of one PHN stock under the Base Case scenario is 41.88 EUR. Compared to the current market price of 47.4 EUR, Pharmanutra SpA is Overvalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PHN Relative Value
Base Case
41.88 EUR
Overvaluation 12%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.5
P/S
P/S
Price to Sales
4.5
vs History
52
vs Industry
10
Median 3Y
5.6
Median 5Y
4.8
Industry
1.1
Forward
4
More Details
35.5
P/E
P/E
Price to Earnings
35.5
vs History
23
vs Industry
15
Median 3Y
29.2
Median 5Y
24.9
Industry
18.2
Forward
25.1
More Details
37.7
P/OCF
P/OCF
Price to OCF
37.7
vs History
34
vs Industry
8
Median 3Y
39
Median 5Y
31.3
Industry
11.7
More Details
49.9
P/FCFE
P/FCFE
Price to FCFE
49.9
vs History
22
vs Industry
10
Median 3Y
36.7
Median 5Y
34
Industry
17.2
More Details
8.4
P/B
P/B
Price to Book Value
8.4
vs History
66
vs Industry
4
Median 3Y
11.6
Median 5Y
9.4
Industry
1.6
More Details
4.7
EV/S
EV/S
Enterprise Value to Sales
4.7
vs History
46
vs Industry
10
Median 3Y
5.6
Median 5Y
4.5
Industry
1.2
Forward
4.1
More Details
4.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.8
vs History
47
vs Industry
36
Median 3Y
5.7
Median 5Y
4.7
Industry
3.9
More Details
17.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.9
vs History
42
vs Industry
18
Median 3Y
19.3
Median 5Y
16.4
Industry
10.8
Forward
16.1
More Details
20.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.2
vs History
38
vs Industry
20
Median 3Y
20.4
Median 5Y
18.2
Industry
13.8
Forward
18.2
More Details
39.2
EV/OCF
EV/OCF
Enterprise Value to OCF
39.2
vs History
30
vs Industry
8
Median 3Y
38.6
Median 5Y
29.9
Industry
11.8
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
7
Median 3Y
24.7
Median 5Y
27.9
Industry
15.4
More Details
5.1
EV/IC
EV/IC
Enterprise Value to IC
5.1
vs History
88
vs Industry
10
Median 3Y
10.9
Median 5Y
9.2
Industry
1.3
More Details

Multiples Across Competitors

PHN Competitors Multiples
Pharmanutra SpA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IT
Pharmanutra SpA
MIL:PHN
455.8m EUR 4.5 35.5 17.9 20.2
FR
L'Oreal SA
PAR:OR
244.3B EUR 5.9 39.5 26.2 32
UK
Unilever PLC
LSE:ULVR
107.5B GBP 2.1 19.3 198 229.5
IN
Hindustan Unilever Ltd
NSE:HINDUNILVR
5.5T INR 8.8 52.9 36.3 39.5
US
Estee Lauder Companies Inc
NYSE:EL
48.7B USD 3.2 75.8 25 40.9
UK
HALEON PLC
LSE:HLN
30.6B GBP 2.7 28.2 13 14.6
DE
Beiersdorf AG
XETRA:BEI
32.8B EUR 3.5 44.5 16.8 22.4
JP
Kao Corp
TSE:4452
3.2T JPY 2.1 72.7 17.7 36.1
IN
Godrej Consumer Products Ltd
NSE:GODREJCP
1.3T INR 9.5 74.2 43.6 47.8
JP
Shiseido Co Ltd
TSE:4911
1.9T JPY 1.9 87 21 103.2
IN
Dabur India Ltd
NSE:DABUR
964.2B INR 7.9 53.7 41 48.7

See Also

Summary
PHN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PHN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PHN stock valuation using valuation multiples.
Wall Street Estimates
PHN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PHN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.